Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic LeukemiaFrancesco Lo‐Coco, Uwe Platzbecker, Paola Fazi et al.|New England Journal of Medicine|2013Cited by 1.6k
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinantsRoland J. Fuchs, Rüdiger Hehlmann, Michael Lauseker et al.|Leukemia|2017Cited by 339
Gemtuzumab Ozogamicin in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III StudyRichard F. Schlenk, Hartmut Döhner, Peter Paschka et al.|Journal of Clinical Oncology|2019Cited by 111
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use programKai Hübel, Nicolaus Kröger, Maximilian M. Fresen et al.|Bone Marrow Transplantation|2010Cited by 79